BrianAJackson / iStockphoto.com
Amphastar Pharmaceuticals has succeeded in a jury trial against biotech company Momenta Pharmaceuticals and Sandoz, providing Amphastar with a way out of a patent suit over a blood thinning drug.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Amphastar Pharmaceuticals, Momenta Pharmaceuticals, patent, patent infringement, Lovenox, US District Court for the District of Massachusetts, Sandoz